Seminars in Nuclear Medicine
Volume 32, Issue 1 , Pages 13-34, January 2002

Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders

  • Andrew Newberg
    • ,
  • Abass Alavi

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Abass Alavi, MD, Division of Nuclear Medicine, Hospital of the University of Pennsylvania, 110 Donner Bldg, 3400 Spruce St, Philadelphia, PA 19104.
    • ,
  • Martin Reivich

Functional brain imaging using 18F fluorodeoxyglucose (FDG) and positron emission tomography (PET) has greatly enhanced our understanding of brain function both in normal conditions as well as in a wide variety of neuropsychiatric disorders. We review the uses of FDG PET in the diagnosis, management, and follow-up of patients with neuropsychiatric disorders. This article will also explore what FDG-PET imaging has revealed in these neuropsychiatric disorders and how these findings relate to both research and clinical applications.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(02)80037-X

doi:10.1053/snuc.2002.29276

Seminars in Nuclear Medicine
Volume 32, Issue 1 , Pages 13-34, January 2002

Article Tools